![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 46, 32574-32579, November 12, 1999
From the The A126 cell line, a derivative of PC12, is
defective in cAMP-induced transcription and does not differentiate in
the presence of cAMP. In these cells overexpression of a
cAMP-dependent protein kinase (PKA) anchor protein, AKAP75,
and of the PKA catalytic subunit substantially increased the fraction
of PKAII bound to the membrane, stimulated the transcription of
cAMP-induced genes, and induced terminal differentiation. Conversely,
wild type PC12 cells expressing a derivative of the AKAP75 protein,
AKAP45, which binds the PKA regulatory subunits RII, but fails to
locate them to the membranes, induced translocation of PKAII to the
cytosol. These cells did not efficiently accumulate PKA catalytic
subunit in the nuclei when stimulated with cAMP, did not transcribe
cAMP-induced genes, and failed to differentiate when exposed to cAMP.
These data indicate that membrane-bound PKA positively controls the transcription of cAMP-induced genes and differentiation in PC12 cells.
The growth and differentiation of several cell types are
controlled by cAMP (1-3). In eukaryotes, cAMP binds the regulatory (R)
subunit of cAMP-dependent protein kinases
(PKA).1 This binding releases
the catalytic subunit (C-PKA) which phosphorylates a wide range of
substrate proteins. A fraction of the C-PKA migrates to the nucleus and
phosphorylates nuclear proteins and transacting factors (4-6).
The distinctive characteristics of PKA are largely determined by the
structure and properties of their R subunits (3, 7, 8). PKAI,
consisting of RI type subunits, is typically cytosolic, whereas PKAII,
consisting of type II R subunits ( We have used PC12 as a model system to study the transmission of cAMP
signals under well defined conditions. PC12 cells terminally differentiate in neurons when exposed to cAMP (1, 14). The activation
of differentiation program by cAMP depends on the transcription of
cAMP-induced genes (4, 6). A PC12 derivative cell line has been
isolated, which proliferates and does not differentiate when exposed to
cAMP. This cell line, A126, efficiently differentiates when treated
with NGF or other agents which stimulate protein kinase C or Ras,
indicating that the cAMP and Ras pathways are independently required
for the execution of the differentiation program in PC12 cells (14,
15).
The A126 cells fail to transcribe cAMP-induced genes, although they
normally grow in presence of the cyclic nucleotide. These cells contain
mostly cytosolic PKAII, and we have provided evidence suggesting that
the failure to activate cAMP-induced genes is because of the loss of
membrane-bound PKAII (16).
Here, we show that A126 cells, overexpressing the anchor protein AKAP75
and the catalytic subunit of PKA, significantly increase the fraction
of membrane-bound PKA. These cells transcribe cAMP-induced genes and
differentiate when exposed to cAMP, becoming undistinguishable from
wild type PC12 cells. These data indicate that membrane-bound PKA
positively controls cAMP-dependent transcription and
terminal differentiation in PC12 cells.
Cell Lines--
PC12 and A126 1B2 cells were grown in RPMI
medium containing 5% fetal calf serum, 10% horse serum, 100 units/ml
penicillin, 100 µg/ml streptomycin, and 2 mM glutamine.
Plasmids and DNA Transfections--
The plasmids used in this
study were the following: CRE-CAT (17); C-PKA (2); AKAP75 and AKAP45
(18, 19, 21); RSV-lacZ (20); and RSV-NEO (21). Transfections
were performed by calcium phosphate (21). Stable transfectants were
generated as follows. 107 cells/100-mm dish were
transfected with a total amount of 20 µg of DNA: 5 µg of RSV-NEO, 5 µg of AK75, 5 µg of C-PKA, and salmon sperm to 20 µg. 72 h
later, the cells were split and fresh medium was added. Selection was
carried in G418 for 3 weeks. Single colonies (~50) were pooled and
expanded for further studies. Transient transfections were carried with
a total amount of 10 µg of DNA: 5 µg of CRE-CAT and 5 µg
RSV-lacZ. 44 h later, the cells were stimulated with
0.5 mM 8-Br-cAMP for 4 h. CAT activity was assayed in
extracts containing equivalent units of Fractionation of Cell Extracts--
The cells were washed with
phosphate-buffered saline and lysed mechanically as described
previously (1). The pellet was treated with AT buffer (15 mM NaCl, 60 mM KCl, 15 mM Hepes (pH 7.8), 2 mM EDTA, 0.3 M sucrose, 14 mM Ligand Blotting Analysis or Overlay--
50 µg of proteins
were subjected to electrophoresis in 10% SDS-PAGE. The proteins were
transferred to nitrocellulose filters (0.45 mm Schleicher & Schuell)
and probed with purified RII Immunoblot Analysis--
Cytosolic or membrane proteins were
resolved by SDS-PAGE, transferred to nitrocellulose rinsed in TBST (10 mm Tris-HCl, pH 8, 150 mm NaCl, 0.05% Tween 20), incubated with
anti-RII Nuclear and Cytoplasmic PKA assays--
The cells were lysed in
AT buffer containing 0.1% Triton X-100 by incubation for 5 min on ice.
The lysate was layered on 1 volume of a sucrose cushion (AT buffer
containing 1 M sucrose) and centrifuged at 2,500 × g for 5 min. The pellet represents purified nuclei, and the
upper phase contains the cytoplasm. The nuclear fraction contained
~90% of the transcription factors: TTF1, CREB, and PAX8 (21). Each
preparation was stained with propidium iodide to check purity. PKA
assays (final volume 25 µl) were performed at 30 °C for 10 min in
a solution containing 100 µM ATP,
[ Neurite Outgrowth Assay--
Cells (2-4 × 104) grown in RPMI medium were induced with 1 mM 8-Br-cAMP for 12 days and 100 ng/ml NGF (Upstate
Biotechnology Inc.) for 5 days. The cells received fresh medium
supplemented with 8-Br-cAMP or NGF at 2-day intervals. A neurite was
identified as a process whose length was 1.5 times the cell body. 200 cells were counted for each plate, and the percentage of cells with neurites was calculated as described (15).
RNA Analysis--
Total RNA (30 µg) was size-fractionated in
2.2 M formaldehyde:1% agarose gel and transferred to
N-Hybond filters (Amersham Pharmacia Biotech). Hybridization was
performed at 42 °C for 15 h in 50% formamide, 0.1% SDS, 5×
SSC, 5× Denhardt's solution. The filters were washed at 42 °C in
0.2× SSC (22).
Relocation of PKAII to the Membranes Amplifies cAMP-induced
Transcription and Reverses the Differentiation Block in A126
Cells--
A126 cells do not differentiate when exposed to cAMP
because cAMP-stimulated transcription is defective. We previously found that these cells contain mostly cytosolic PKAII, and we have provided evidence suggesting that the failure to activate cAMP-sensitive genes
was dependent on the absence of membrane-bound PKAII (16). To prove
that when PKAII is localized to the membranes it can reactivate
cAMP-induced transcription, we transfected A126 cells with plasmid
constructs expressing the RII-binding protein AKAP75, or the catalytic
subunit of PKA, or both genes. Stable transfectants were selected,
pooled (~50 for each DNA construct), analyzed for the expression of
the plasmid vectors, and further characterized. Cells transfected with
C-PKA contained two-fold higher PKA activity compared with NEO or
AKAP75 transfectants (data not shown). We first determined the
cytosolic/membrane partition of endogenous RII subunits in transfected
cells. Fig. 1 shows RII
To determine the biological effects of membrane-bound PKA, we tested
cAMP-induced transcription in the cells mentioned above by assaying the
transient expression of CAT driven by a cAMP-induced promoter (CRE).
Fig. 2 shows that cAMP-induced
transcription was markedly stimulated in the cells transfected with
C-PKA and AKAP75. The effects of AKAP75 and C-PKA were synergistic,
indicating that the increase in total PKA by C-PKA and membrane
anchoring by AKAP75 expression independently contributed to the
stimulation of cAMP-induced transcription, defective in A126 cells
(Fig. 2).
A126 cells were originally isolated as cells resistant to cAMP-induced
differentiation, we therefore tested whether the expression of AKAP75
and C-PKA could rescue this phenotype. Fig.
3A shows that A126 cells
expressing exogenous AKAP75 and C-PKA (A75+C-PKA) differentiated efficiently when stimulated with cAMP (75% of the cells
showed neurite outgrowth versus 10% in control cells). This effect was cAMP-dependent since these cells did not
differentiate in the absence of cAMP (Fig. 3A,
A75+C-PKA).
We also measured the growth profile of these cells in the presence of
cAMP (Fig. 3B). The growth of cells expressing AKAP75 and
C-PKA was markedly inhibited by cAMP, whereas control or
mock-transfected cells proliferated in the presence of cAMP for 12 days. Cells expressing AKAP75 or C-PKA alone proliferated more slowly
than control A126 cells in the presence of cAMP. These data indicate that relocation of PKA to the membrane reverses the block in
cAMP-induced transcription and restores cAMP-induced
differentiation in A126 cells.
Cytosolic Translocation of PKAII Inhibits cAMP-induced
Transcription and Blocks the Differentiation in PC12 Cells--
The
experiments shown above indicate that membrane-bound PKA stimulates the
transcription of cAMP-induced genes and the differentiation of A126
cells. To conclusively determine the role of membrane-bound PKA in the
amplification of cAMP signals, we performed the complementary experiment. We expressed in the wild type PC12 cells a derivative of
AKAP75 protein, which contains a deletion at the NH terminus. Since
this segment of the protein contains the protein domain which is
necessary for membrane binding, overexpression of this mutant, AKAP45,
translocates RII and PKAII to the cytosol (24).
PC12 stable transfectants expressing AKAP45 were isolated and analyzed
by immunoblot with anti-RII
PKA activation by cAMP was measured in these cells. Fig.
5 shows that cAMP-induced accumulation of
nuclear C-PKA was substantially reduced in AKAP45-expressing cells
compared with control cells (Fig. 5, upper panel). Also,
cytoplasmic PKA was not efficiently activated by cAMP (Fig. 5,
lower panel) or forskolin (data not shown), when compared
with control cells. It is of interest to note that inefficient PKA
activation was found in A126 cells, which are refractory to
cAMP-induced differentiation (14, 16). The ratio PKAII/PKAI in PC12
expressing AKAP45 was unchanged compared with wild type PC12 (data not
shown). Total PKA in PC12-A45 was ~80% of that found in wild type
PC12 (see legend of Fig. 5).
Nuclear cAMP signaling in PC12 cells expressing A45 was significantly
down-regulated as shown by inefficient accumulation of nuclear C-PKA
following cAMP stimulation (Fig. 5, upper panel). Activation
of transcription of a CRE promoter following cAMP stimulation was
reduced in terms of magnitude and kinetics (Fig.
6). PC12 cells exposed to cAMP stop
growing and differentiate (14, 15).
We have determined the growth rate of PC12 expressing AKAP45 in the
presence or absence of cAMP. The left panel in Fig.
7 shows that the growth of these cells is
not inhibited by cAMP as control cells. Furthermore, the induction of
differentiation genes (c-Fos, H-Ferritin, and vgf) by cAMP was
significantly depressed in A45-expressing cells (Fig. 7, right
panel). The induction of the same genes by NGF was unchanged in
AKAP45-expressing cells. Neurite outgrowth, a very sensitive marker of
cAMP biological response in PC12 cells, was significantly depressed in
PC12-A45 cells (Fig. 8B).
Table I summarizes the data and
illustrates that the expression of A45 in PC12 cells, which results in
translocation of PKAII to the cytosol, down-regulates the cAMP
biological response.
cAMP induces terminal differentiation of PC12 cells. This effect
is mediated by the stimulation of transcription of cAMP-responsive genes (16, 25). The mutant cell line A126 is defective in cAMP-induced
transcription and does not differentiate when exposed to cAMP (14, 26).
PKA is present and active, albeit reduced, but is localized exclusively
in the cytosol (16). Expression of a PKA anchor protein, AKAP75,
relocates PKAII to the membranes and activates cAMP-induced
transcription. Co-expression of C-PKA and AKAP75 completely reverses
the block of cAMP-induced transcription and differentiation. Note that
C-PKA or AKAP75 alone did not restore cAMP-induced transcription in
A126 cells (Fig. 2 and Ref. 16). On the other hand, C-PKA is also
required for membrane localization of RII A126 cells were selected for their ability to grow in the presence of
high cAMP concentrations (14).These cells became resistant to cAMP
inhibition of growth probably by reducing the pool of membrane-bound
PKAII (Fig. 1). However, we cannot exclude that the A126 phenotype
might result from other yet unknown mutations in pathways directly or
indirectly affecting cAMP signaling. One way to demonstrate the
cause-effect relationship between membrane-bound PKA and cAMP-induced
differentiation was to generate the A126 defective phenotype in wild
type PC12 by manipulating only the localization of endogenous PKA. The
experiments shown here indicate that the expression of a mutated
variant of AKAP75, AKAP45, which binds RII but fails to localize it to
the membranes, alters the membrane-cytosol partition of RII and
significantly increases the fraction of cytosolic RII. cAMP-induced
nuclear accumulation of C-PKA and cAMP-induced transcription are
significantly down-regulated in these transfectants, indicating that
membrane-bound PKA positively regulates cAMP-induced transcription
(Fig. 6). The effects elicited by AKAP45 are solely dependent on RII
binding because this mutant does not bind membrane, PKC, or
calcineurin (19, 21). Recently, we have shown that a version of AKAP45,
which does not bind RII, does not down-regulate cAMP-induced
transcription.2
PC12 cells expressing AKAP45 mimic A126 mutant cells and become
refractory to cAMP signaling. Thus, these cells proliferate and fail to
differentiate when exposed to cAMP. Biochemical comparative analysis of
PC12 cells expressing AKAP45 indicate that they are very similar to
A126 because 1) endogenous cAMP levels are not altered (Ref. 16, and
data not shown), 2) cytoplasmic PKA is not efficiently activated by
cAMP in PC12-A45 and A126 cells (Ref. 16, and Fig. 5), and 3) the
expression of RII-binding proteins is down-regulated (Figs. 1 and 4).
We have previously shown that A126 cells contain an excess of R
subunits in the cytosol that efficiently buffers exogenous C-PKA, added
to the extracts. Thus, PKA in these cells is efficiently activated
in vitro but not in vivo (16). We have reproduced
this phenotype in PC12 that express AKAP45, which do not respond to
cAMP (Figs. 5 and 8). We suggest that excess of R subunits in the
cytosol inhibits PKA dissociation and reduces
cAMP-dependent activation of the enzyme. PC12 cells expressing AKAP45 show the same PKA phenotype as A126 cells.
As to the endogenous PKA anchor proteins in PC12, a comparative
analysis of the overlay blots of the AKAP45 and AKAP75 transfectants indicates that 1) two major protein species binding RII are present in
the membranes of PC12 cells, one ~150 kDa and the other ~85 kDa of
molecular mass (Fig. 4, panel A); 2) the expression of both
proteins is reduced in A126 and PC12-A45 cells; and 3) the level of
expression of each of the endogenous RII-binding proteins is modulated
differently in response to cAMP signaling (Fig. 1, panel A,
see also Ref. 27 for cAMP-induced AKAP). The reduction of the AKAP
proteins in A126 might be a consequence of the down-regulation of the
expression of cAMP-induced genes (27). This further down-regulated cAMP-induced transcription and differentiation. The definition of the
biological roles of the PC12 AKAPs requires the molecular cloning of
the species indicated above. In conclusion, we have demonstrated that
membrane-bound PKA amplifies cAMP signals to the nucleus, and
it is essential in cAMP-induced differentiation of PC12 cells.
We especially thank Graciana Diez-Roux for
the critical comments to the manuscript and Dr. C. Rubin for providing
antibodies to AKAP75 protein.
*
This work was supported by grants from "Associazione
Italiana per la Ricerca sul Cancro (A.I.R.C.)," CNR targeted Project "Biotecnologie", and MURST (Italian Department of University and Research).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
2
Feliciello, A., Gallo, A., Porcellini, A.,
Hesman, M. E., and Avvedimento, E. V. (1999) J. Biol. Chem.,
(in press).
The abbreviations used are:
PKA, cAMP-dependent protein kinase;
C-PKA, catalytic subunit of
PKA;
NGF, nerve growth factor;
PKC, protein kinase C;
RSV, Rous sarcoma
virus;
8-Br-cAMP, 8-bromo-cAMP;
CAT, chloramphenicol
acetyltransferase;
AKAP, A Kinase
Anchor Protein.
Membrane-bound cAMP-dependent Protein Kinase
Controls cAMP-induced Differentiation in PC12 Cells*
,
,
, and
§¶
Centro di Endocrinologia ed Oncologia
Sperimentale del CNR, Dipartimento di Biologia e Patologia Molecolare e
Cellulare, Facoltà di Medicina e Chirurgia, Università
"Federico II" Napoli, 80131 Napoli, Italy and the
§ Dipartimento di Medicina Sperimentale e Clinica,
Facoltà di Medicina e Chirurgia, Università di Catanzaro
"Magna Graecia", 88100 Catanzaro, Italy
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
and
), is targeted to certain
subcellular locations by specific anchor proteins (AKAPs) (3,
9-11).The localization of PKA may improve the accessibility of the
enzyme to upstream and downstream effectors and also to cAMP (10, 11).
We have provided evidence linking membrane targeting of PKAII to
cAMP-dependent gene transcription in differentiated and
non-differentiated cells. In thyroid cells, displacement of immobilized
PKAII from perinuclear sites to the cytoplasm impaired cAMP-induced
transcription of the thyroglobulin gene (12). Also, in non-neuronal
cells positioning of PKAII in the membranes significantly stimulated
the rate and the magnitude of transcription of cAMP-induced promoters
(13).
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-galactosidase (0.1, 0.2 unit), (1 unit is the absorbance at 420 nm of the extracts incubated
with 1 mg/ml 2-nitrophenyl-D-galactopyranoside transferase at 37 °C for 1 h). Experiments showing differences of
lacZ expression more than 2-fold have been eliminated.
-mercaptoethanol) containing 1% Triton X-100 for 15 min at 4 °C and sonicated 3 pulses of 20 s. Preparation of
cytosolic fractions was carried out as described previously
(16).
(a gift of Dr. C. Rubin, New York) that
had been labeled with purified C-PKA and processed as described (16).
The bands corresponding to RII were identified by immunoblot with
specific antibodies (12, 13, 16)
or -RII
antibodies in 5% non-fat dry milk in TBST for
1 h (12, 16). After washing (three times in TBST for 15 min), the
nitrocellulose membranes were incubated with peroxidase-conjugated
anti-rabbit IgG (Amersham Pharmacia Biotech) in 5% in non-fat dry milk
in TBST for 1 h and developed by ECL (16).
-32P]ATP (Amersham Pharmacia Biotech) (125-150
cpm/pmol) at a final concentration of 10 µCi/100 µl of reaction
mixture, 10 mM MgCl2, 20 mM Hepes
(pH 7.4), 100 µM Kemptide (Sigma). When measuring PKA
holoenzyme, 10-50 µM cAMP was added. PKA activity was
fully inhibited by adding a specific PKA inhibitor peptide (10 µM) containing a PKA pseudophosphorylation site (Sigma).
Kemptide phosphorylation was monitored by spotting 20 µl of the
incubation mixture on phosphocellulose filters (Whatman, P81) and
washing with 75 mM phosphoric acid, as described previously
(12). The radioactivity retained on the filters was determined by
scintillation counting in 4 ml of scintillation liquid (Ecolite, ICN).
Free C-PKA activity was evaluated by subtracting cpm obtained in the
absence of cAMP from the values obtained in the presence of PKA
inhibitor peptide. Data were expressed as picomoles of
[32P]phosphate transferred to the peptide substrate
during a 10-min incubation in the presence (PKA holoenzyme) or absence
(free C-PKA) of 10 µM cAMP. At the concentrations used,
PKA inhibitor peptide did not inhibit the binding of phosphorylated
Kemptide to phosphocellulose filters (12, 13, 16).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
and RII
present in the cytosolic (C) and membrane (P)
fractions derived from transfected cells. The blots were analyzed by
ligand blotting assay using labeled RII as the probe (A) or
by immunoblot with specific anti RII
(B) or anti RII
(C) antibodies. Panel A in Fig. 1 shows that
AKAP75 transfected cells contain in the membrane fraction a band which
strongly interacts with labeled RII (lanes indicated by
A75 and A75+C). This band of
approximately 75 kDa corresponds to the exogenous AKAP75 protein (Fig.
1A, lanes 4 and 6). Other RII-binding
proteins of approximately 220, 150, and 85 kDa are present in the
membrane fraction. The 85-90-kDa RII-binding protein is induced in
A126 cells expressing AKAP75 or C-PKA alone (Fig. 1A,
lanes 6 and 8). The 150-220-kDa proteins are
induced in cells expressing AKAP75 (Fig. 1, lane 4). The
levels of these RII binding proteins are high in PC12 and reduced in A126 cells. A minor band of ~52 kDa is detected in the lower part of
the blot. This band corresponds to RII subunits, which are better
defined in the B (RII
) and C (RII
)
panels of Fig. 1. RII
is found exclusively in the cytosol
of A126 cells (Fig. 1, A and B, lanes
1, and Ref. 16). Expression of AKAP75 in combination with C-PKA
subunit significantly increases RII
in the membrane fraction (Fig.
1B, lane 6). In these transfectants, a
significant fraction of RII
translocates to the membranes (see the
histogram below the blot). As to RII
, we did not detect significant
variations relative to control cells (Fig. 1, panel C),
indicating that AKAP75 expression influences predominantly the
membrane-cytoplasmic partition of RII
. This finding might be
explained by the higher binding affinity of AKAP75 to RII
relative
to RII
(23). AKAP75 is limiting in these cells, as demonstrated by
the residual RII
in the cytosol (Fig. 1B). These clones
do not express very high levels of AKAP75, and under these conditions
AKAP75 affects preferentially cytosolic/membrane partition of RII
but not RII
. In transfectants expressing high levels of AKAP75, both
RII
and RII
are targeted to the membranes (data not shown, and
Ref. 13).

View larger version (55K):
[in a new window]
Fig. 1.
Membrane/cytosol partition of RII subunits in
A126 cells expressing AKAP75. A, ligand blotting analysis of
membrane and cytosolic fractions with labeled RII
subunit. Cytosolic
(C) and membrane (P) fractions were prepared as
described previously (16). Purified RII
subunit was labeled with
C-PKA as described under "Materials and Methods." The specific
activity was 3.5·106 cpm/µg. The lane
labeled RII
corresponds to 1 ng of purified protein. Panels
B and C are immunoblots of the same cellular fractions
probed with antibodies to RII
(B) and RII
(C), respectively. The histograms shown in the
lower part of the figure indicate the relative amount of RII
present in the pellet (black) or cytosol (white)
fraction of each cell line indicated by the numbers. The
values on the ordinates, expressed in arbitrary units, were generated
by densitometric scanning of the blots.

View larger version (52K):
[in a new window]
Fig. 2.
cAMP-induced transcription in
A126-transfected cells. The cell lines indicated below
the histogram were transiently transfected with CRE-CAT and
RSV-lacZ and induced for 4 h with 500 µM
8-Br-cAMP. CAT activity, normalized for transfection efficiency with
RSV-lacZ, is shown as -fold induction over the basal. The
basal CAT activity was comparable in PC12 and A126 cells.

View larger version (69K):
[in a new window]
Fig. 3.
Expression of AKAP75 and C-PKA stimulates the
differentiation and inhibits the growth of A126 cells.
A, the cell lines indicated were treated with 8-Br-cAMP (1 mM) for 12 days. Neurite outgrowth was measured as
described under "Materials and Methods." On average, 200 cells were
counted for each plate. The fraction of cells showing neurites in the
presence of cAMP were as follows: RSV-NEO transfected cells, 10 ± 3%; C-PKA-transfected cells, 30 ± 7%; AKAP75-transfected cells,
30 ± 6%; and AKAP75 and C-PKA-transfected, 75 ± 8%,
respectively. B1, growth profiles of the same cell lines
indicated in panel A.
and
, A126 cells expressing
RSV-NEO in the absence or presence of 1 mM 8-Br-cAMP,
respectively;
and
, 126 cells expressing C-PKA in the absence or
presence of 1 mM 8-Br-cAMP, respectively;
and
, A126
cells expressing C-PKA and AKAP75 in the absence or presence of 1 mM 8-Br-cAMP, respectively. B2,
and
,
A126 cells expressing RSV-NEO in the absence or presence of 1 mM 8-Br-cAMP, respectively;
and
, 126 cells
expressing AKAP75 in the absence or presence of 1 mM
8-Br-cAMP, respectively.
- and -RII
-specific antibodies. Fig.
4A shows an overlay experiment
using labeled RII
as probe. In control cells (NEO), we detected two
major RII-binding proteins of size ~110-150 and 85 kDa. These
proteins were not detected in AKAP45-transfected cells. Fig.
4B shows a Western blot of the same extracts with specific
antibodies to bovine the AKAP75 (18). The two arrows
indicate the endogenous AKAP150 (homologous to the bovine AKAP75)
and the exogenous AKAP45 (18). Note that the endogenous AKAP150 was
down-regulated in cells expressing AKAP45. This effect is seen more
dramatically in the overlay blot shown in Fig. 4A. The same
cell extracts were also analyzed by immunoblotting with specific
anti-RII
and anti RII
antibodies. The 52-kDa band corresponds to
the RII subunits, RII
(Fig. 4C) and RII
(Fig.
4D). Expression of AKAP45 significantly increased RII
subunits in the cytosol.

View larger version (38K):
[in a new window]
Fig. 4.
Membrane/cytosol partition of RII subunits in
PC12 cells expressing AKAP45. Pools of PC12 cells transfected with
AKAP45 vector were isolated and analyzed by ligand blotting and
immunoblotting with specific antibodies to RII
and RII
. Cytosolic
and membrane fractions were prepared as described under "Materials
and Methods." Panel A shows a representative overlay
filter probed with labeled RII
. The AKAP45 is not visible in this
blot, since it does not react efficiently with labeled RII after SDS
denaturation. Panel B shows an immunoblot of the same
extracts probed with specific antibodies to AKAP75. The
arrows indicate the endogenous AKAP150 and the exogenous
AKAP45. Panels C and D show representative
immunoblots of the same cellular fractions as in panel A
probed with anti-RII
and anti-RII
antibodies, respectively. The
histograms shown in the lower part of the figure indicate
the relative amount of RII present in the membrane (black)
or supernatant (white) fraction of the transfectants. The
values on the ordinates expressed in arbitrary units were generated by
densitometric scanning of the blots.

View larger version (12K):
[in a new window]
Fig. 5.
cAMP activation of cytoplasmic and nuclear
PKA is impaired in PC12 cells expressing AKAP45. Control PC12
(
) and PC12 expressing A45 cells (
) were stimulated with the
indicated concentrations of 8-Br-cAMP for 40 min. Cytoplasm and nuclear
fractions were purified as described under "Materials and Methods."
Cytoplasmic PKA activation (lower panel) is represented as
the ratio between C-PKA and total PKA, as described under "Materials
and Methods." The absolute amount of total PKA, dissociable in
vitro by cAMP, in PC12 and PC12 expressing AKAP45 was 14.4 ± 0.2 and 11.4 ± 0.5 pmols/µg/min, respectively. Nuclear PKA
activity (upper panel) is shown as picomoles of
[32P]ATP incorporated/10 min/µg of nuclear
proteins.

View larger version (8K):
[in a new window]
Fig. 6.
Inefficient cAMP-induced transcription in
PC12 cells expressing A45. Control PC12 (black) and
PC12 expressing AKAP45 (white) cells were transiently
transfected with CRE-CAT and RSV-lacZ as indicated under
"Materials and Methods." The cells were treated with 0.5 mM 8-Br-cAMP for 4, 10, and 24 h. CAT activity
normalized for transfection efficiency with RSV-lacZ, is
shown as -fold induction over the basal.

View larger version (30K):
[in a new window]
Fig. 7.
cAMP, but not NGF, fails to induce
differentiation genes in PC12 cells expressing AKAP45. Control
PC12-NEO (
) and AKAP45 (
) transfected cells in triplicates were
stimulated with 1 mM 8-Br-cAMP (PC12-NEO,
;
AKAP45-expressing cells,
) for the periods indicated in the figure
(left panel).The cell number was determined at the indicated
time intervals. The initial cell concentration was 0.5 × 105 cells per dish, the culture medium was changed every 3 days. The results shown are the average data from two independent
experiments. The right panel shows the RNA analysis of
control (NEO) and AKAP45 expressing cells. The cells were
starved from serum for 5 h and induced for 4 h with 0.5 mM 8-Br-cAMP or 100 ng/ml NGF. Total RNA was isolated and
analyzed as indicated under "Materials and Methods." The specific
cDNA probes used were rat c-Fos (17), human H-Ferritin (28), rat
vgf (29) and rat 28 S RNA.

View larger version (122K):
[in a new window]
Fig. 8.
PC12 expressing AKAP45 do not differentiate
when exposed to cAMP. Control and AKAP45 expressing (A45) cells
were plated at the concentration of 5 × 104 and
induced with 1 mM 8-Br-cAMP for 12 days (panels
A and B, respectively). Panel C shows PC12
expressing AKAP45 stimulated with NGF (100 ng/ml) for 3 days.
Overexpression of AKAP-45 inhibits cAMP-induced differentiation in PC12
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
because the expression of
RII
binding proteins is stimulated by PKA (Fig. 1, panel
A and Ref. 27).
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1.
Corbitt, J.,
Vivekananda, J.,
Wang, S. S,
and Strong, R.
(1998)
J. Neurochem.
71,
478-486[Medline]
[Order article via Infotrieve]
2.
Mellon, P.,
Clegg, C. H.,
Correl, L. A.,
and McKnight, S.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
4887-4891 3.
Taylor, S. S.,
Buechler, J. A.,
and Yonemoto, W.
(1990)
Annu. Rev. Biochem.
59,
971-1005[CrossRef][Medline]
[Order article via Infotrieve]
4.
Hagiwara, M.,
Brindle, P.,
Harootunian, A.,
Armstrong, R.,
Rivier, J.,
Vale, W.,
Tsien, R.,
and Montminy, M. R.
(1993)
Mol. Cell. Biol.
13,
4852-4859 5.
Montminy, M. R.,
and Bilezikjian, L. M.
(1987)
Nature
328,
175-178[CrossRef][Medline]
[Order article via Infotrieve]
6.
Montminy, M. R.
(1997)
Annu. Rev. Biochem.
66,
807-822[CrossRef][Medline]
[Order article via Infotrieve]
7.
Hofmann, F.,
Beavo, J. A.,
Bechte, P. J.,
and Krebs, E. G.
(1975)
J. Biol. Chem.
250,
7795-7801 8.
Taylor, S. S.
(1989)
J. Biol. Chem.
264,
8443-8446 9.
Glanz, S. B.,
Amat, J. A.,
and Rubin, C. S.
(1992)
Mol. Biol. Cell
3,
1215-1228[Abstract]
10.
Rubin, C. S.
(1994)
Biochim. Biophys. Acta
1224,
467-479[Medline]
[Order article via Infotrieve]
11.
Scott, J. D.,
and McCartney, S.
(1994)
Mol. Endocrinol.
8,
5-11[CrossRef][Medline]
[Order article via Infotrieve]
12.
Feliciello, A.,
Giuliano, P.,
Porcellini, A.,
Garbi, C.,
Obici, S.,
Mele, E.,
Angotti, E.,
Grieco, D.,
Amabile, G.,
Cassano, S.,
Li, Y.,
Musti, A. M.,
and Rubin, C. S.
(1996)
J. Biol. Chem.
271,
25350-25359 13.
Feliciello, A.,
Li, Y.,
Avvedimento, V. E.,
Gottesman, M. E.,
and Rubin, C. S.
(1997)
Curr. Biol.
7,
1011-1014[CrossRef][Medline]
[Order article via Infotrieve]
14.
Van Buskirk, R.,
Corcoran, T.,
and Wagner, J. A.
(1985)
Mol. Cell. Biol.
5,
1984-1992 15.
Damon, D. H.,
D'Amore, P. A.,
and Wagner, J.
(1990)
Cell Biol.
110,
1333-1339
16.
Cassano, S.,
Gallo, A.,
Buccigrossi, V.,
Porcellini, A.,
Cerillo, R.,
Gottesman, M. E.,
and Avvedimento, V. E.
(1996)
J. Biol. Chem.
271,
29870-29875 17.
Sassone-Corsi, P.,
Visvader, J.,
Ferland, L.,
Mellon, P. L.,
and Verma, I. M.
(1988)
Genes Dev.
2,
1529-1538 18.
Hirsh,
Allen, H.,
Glantz, S. B.,
Li, Y.,
You, Y.,
and Rubin, C. S.
(1992)
J. Biol. Chem.
267,
2131-2134 19.
Ndubuka, C.,
Li, Y.,
and Rubin, C. S.
(1993)
J. Biol. Chem.
268,
7621-7624 20.
Kaang, B. K.,
Pfaffinger, P. J.,
Grant, S. G. N., E.,
Kandel, R.,
and Furukawa, Y.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
1133-1137 21.
Gallo, A.,
Benusiglio, E.,
Bonapace, I. M.,
Feliciello, A.,
Cassano, S.,
Garbi, C.,
Musti, A. M.,
Gottesman, M. E.,
and Avvedimento, V. E.
(1992)
Genes Dev.
6,
1621-1633 22.
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, 2nd Ed.
, pp. 7.3-7.8, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
23.
Leiser, M.,
Rubin, C. S.,
and Erlichman, J.
(1986)
J. Biol. Chem.
261,
1904-1908 24.
Glanz, S. B.,
Li, Y.,
and Rubin, C. S.
(1993)
J. Biol. Chem.
268,
12796-12804 25.
Kim, K.-S.,
Ishiguro, H.,
Tinti, C.,
Wagner, J.,
and Joh, T. H.
(1994)
J. Neurosci.
14,
7200-7207[Abstract]
26.
Henderson, L. P.,
Gdovin, M. J.,
Liu, C.,
Gardner, P. D.,
and Maue, R. A.
(1994)
J. Neurosci.
14,
1153-1163[Abstract]
27.
Feliciello, A.,
Rubin, C. S.,
Avvedimento, E. V.,
and Gottesman, M. E.
(1998)
J. Biol. Chem.
273,
23361-23366 28.
Ursini, M. V.,
and De Franciscis, V.
(1988)
Biochem. Biophys. Res. Commun.
150,
287-295[CrossRef][Medline]
[Order article via Infotrieve]
29.
Possenti, R.,
Di Rocco, G.,
and Levi, A.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
89,
3815-3819
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Ghil, J.-M. Choi, S.-S. Kim, Y.-D. Lee, Y. Liao, L. Birnbaumer, and H. Suh-Kim Compartmentalization of protein kinase A signaling by the heterotrimeric G protein Go PNAS, December 12, 2006; 103(50): 19158 - 19163. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Fetalvero, M. Shyu, A. P. Nomikos, Y.-F. Chiu, R. J. Wagner, R. J. Powell, J. Hwa, and K. A. Martin The prostacyclin receptor induces human vascular smooth muscle cell differentiation via the protein kinase A pathway Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1337 - H1346. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kotera, T. Sasaki, T. Kobayashi, K. Fujishige, Y. Yamashita, and K. Omori Subcellular Localization of Cyclic Nucleotide Phosphodiesterase Type 10A Variants, and Alteration of the Localization by cAMP-dependent Protein Kinase-dependent Phosphorylation J. Biol. Chem., February 6, 2004; 279(6): 4366 - 4375. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Porcellini, S. Messina, G. De Gregorio, A. Feliciello, A. Carlucci, M. Barone, A. Picascia, A. De Blasi, and E. V. Avvedimento The Expression of the Thyroid-stimulating Hormone (TSH) Receptor and the cAMP-dependent Protein Kinase RII {beta} Regulatory Subunit Confers TSH-cAMP-dependent Growth to Mouse Fibroblasts J. Biol. Chem., October 17, 2003; 278(42): 40621 - 40630. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Affaitati, L. Cardone, T. de Cristofaro, A. Carlucci, M. D. Ginsberg, S. Varrone, M. E. Gottesman, E. V. Avvedimento, and A. Feliciello Essential Role of A-kinase Anchor Protein 121 for cAMP Signaling to Mitochondria J. Biol. Chem., January 31, 2003; 278(6): 4286 - 4294. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Altier, S. J. Dubel, C. Barrere, S. E. Jarvis, S. C. Stotz, R. L. Spaetgens, J. D. Scott, V. Cornet, M. De Waard, G. W. Zamponi, et al. Trafficking of L-type Calcium Channels Mediated by the Postsynaptic Scaffolding Protein AKAP79 J. Biol. Chem., September 6, 2002; 277(37): 33598 - 33603. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Indolfi, E. Stabile, C. Coppola, A. Gallo, C. Perrino, G. Allevato, L. Cavuto, D. Torella, E. Di Lorenzo, G. Troncone, et al. Membrane-Bound Protein Kinase A Inhibits Smooth Muscle Cell Proliferation In Vitro and In Vivo by Amplifying cAMP-Protein Kinase A Signals Circ. Res., February 16, 2001; 88(3): 319 - 324. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |